Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
By C. Prado, Vickie E. Baracos, L. Mccargar, T. Reiman, M. Mourtzakis, K. Tonkin, John R. Mackey, S. Koski, E. Pituskin, M. Sawyer. Clinical Cancer Research, 2009
1,017 citations recorded by the source corpus.
Subfields: Oncology, Physiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/4ee1ada455c8e498fd8ad273a6b15e12669dfda8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Physiology
Citations in the corpus
- Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery (2012, background): “Sarcopenia has been associated with reduced survival and chemotherapy treatment toxicity (Prado et al, 2008, 2009, 2011; Antoun et al, 2010; van Vledder et al, 2012).”
- Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. (2016, background): “In patients with advanced cancer, the poor outcomes may be related to higher toxicity rates, which in turn, may lead to dose reductions and delivering lower doses of effective cancer treatments [55].”